Niacin as a potential AIDS preventive factor

Medical Hypotheses

Volumn 53, Issue 5, 1999, Pages 375-379

  Murray, M F ^a  

^a Tewksbury Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC ACID; TRYPTOPHAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DIET; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS INHIBITION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032750720     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0908     Document Type: Article

References (44)

1. Castiello R. J., Lynch P. J. Pellagra and the carcinoid syndrome. Arch Derm. 105:1972;574-577.
2. Waldenstrom J., Ljungberg E. Studies on the functional circulatory in3/4uence from metastasizing carcinoid tumours and their possible relation to enteramine production. Acta Med Scand. 152:1955;293-309.
3. Hussey G. D., Klein M. Measles induced vitamin A deficiency. Ann NY Acad Sci. 669:1992;188-194.
4. Ho D. D. Dynamics of HIV-1 replication in vivo. J Clin Invest. 99:1997;2565-2567.
5. Piot P. The science of AIDS: a tale of two worlds. Science. 280:1998;1844-1845.
6. Bollet A. J. Politics and pellagra: the epidemic of pellagra in the US in the early twentieth century. Yale J Biol Med. 65:1992;211-221.
7. Elvehjam C. A., Madden R. J., Strong F. M., Woolley D. W. Relation of nicotinic acid and nicotinic acid amide to canine black tongue. J Am Chem Soc. 59:1937;1767-1768.
8. Truswell A. S., Hansen J. D. L., Wannenburg P. Plasma tryptophan and other amino acids in pellagra. Am J Clin Nutr. 21:1968;1314-1320.
9. Shibata K., Hayakawa T., Taguchi H., Iwai K. Regulation of pyridine nucleotide coenzyme metabolism. Schwarcz R. Kyurenine and Serotonin Pathways. 1991;Plenum Press, New York.
10. Peters J. C. Tryptophan nutrition and metabolism: an overview. Schwarcz R. Kyurenine and Serotonin Pathways. 1991;Plenum Press, New York.
11. Heyes M. P. Metabolism and neuropathologic signi1/2cance of quinolinic acid and kynurenic acid. Biochem Soc Trans. 21:1993;83-89.
12. Henderson L. M. Niacin. Ann Rev Nutr. 3:1983;289-307.
13. Spivak J. L., Jackson D. L. Pellagra: an analysis of 18 patients and a review of the literature. Johns Hopkins Med J. 140:1977;295-309.
14. Fu C. S., Swendseid M. E., Jacob R. A., McKee R. W. Biochemical markers for assessment of niacin status in young men: levels of erythrocyte niacin coenzymes and plasma tryptophan. J Nutr. 19:1989;1949-1955.
15. Soeprono F. F., Schinella R. A., Cockerell C. J. Seborrheic-like dermatitis of acquired immunodeficiency syndrome. J Am Acad Dermatol. 14:1985;242-248.
16. Greenson J. K., Belitsos P. C., Yardley J. H., Bartlett J. G. AIDS enteropathy: occult enteric infections and duodenal alterations in chronic diarrhea. Ann Intern Med. 114:1991;366-372.
17. Ullrich R., Zeitz M., Heise W., L'age M., Hoffken G., Riecken E. O. Small intestinal structure and function in patients infected with HIV: evidence for HIV-induced enteropathy. Ann Intern Med. 111:1989;15-21.
18. Everall I. P., Luthert P. J., Lantos P. L. Neuronal loss in the frontal cortex of HIV infection. Lancet. 337:1991;1119-1121.
19. DeGirolami U., Smith T. W., Henin D., Hauw J. J. Neuropathology of the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 114:1990;643-655.
20. Foudraine N. A., Weverling G. J., VanGool T. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS. 12:1998;35-41.
21. Skolnick A. A. Protease inhibitors may reverse AIDS dementia. JAMA. 279:1998;419.
22. Tabucchi A., Carlucci F., Consolmagno E. Changes in purine nucleotide content in the lymphocyte subpopulations of patients infected with HIV. Clinica Chimica Acta. 225:1994;147-153.
23. Bofill M., Fairbanks L. D., Ruckemann K., Lipman M., Simmonds H. A. T-lymphocytes from AIDS patients are unable to synthesize ribonucleotides de novo in response to mitogenic stimulation. J Biol Chem. 270:1995;29690-29697.
24. Murray M. F., Nghiem M., Srinivasan A. HIV infection decreases intracellular nicotinamide adenine dinucleotide. Biochem Biophys Res Commun. 212:1995;126-131.
25. Carlucci F., Tabucchi A., Rosi F. Purine ribonucleotide content in infected HIV-RT+ and HIV-RT- lymphoblastoid cell lines. Biomed Pharmacother. 50:1996;158-162.
26. Hortin G. L., Landt M., Powderly W. G. Changes in plasma amino acid concentrations in response to HIV-1 infection. Clin Chem. 40:1994;785-789.
27. Fuchs D., Moller A. A., Reinegger G. Increased endogenous interferon-gamma and neopterin coorelate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immun Lett. 28:1991;207-212.
28. Sardar A. M., Bell J. E., Reynolds G. P. Increased concentrations of the neurotoxin 3-hydrokynurenine in the frontal cortex of HIV-1 positive patients. J Neurochem. 64:1995;932-935.
29. Gisslen M., Larsson M., Norkrans G., Fuchs D., Wachter H., Hagber L. Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection. AIDS Res Hum Retrovir. 10:1994;947-951.
30. Murray M. F., Srinivasan A. Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection. Biochem Biophys Res Commun. 210:1995;954-959.
31. Abrams B., Duncan D., Hertz-Picciotto I. A prospective study of dietary intake and acquired immune de1/2ciency in HIV- seropositive homosexual men. J AIDS. 6:1993;949-958.
32. Tang A. M., Graham N. M. H., Saah A. J. Effects of micronutrient intake on survival in human immunode1/2ciency type 1 infection. Am J Epidemiol. 143:1996;1244-1256.
33. Ubbink J. B., Vermaak W. J. H., Bissobort S. H. High preformance liquid chromatographic assay of human lymphocyte kynureninase activity levels. J Chromat. 566:1991;369-375.
34. Sharkey S. J., Sharkey K. A., Sutherland J. R. Nutritional status and food intake in human immunode1/2ciency virus infection. J AIDS. 5:1992;1091-1098.
35. MMWR. 38:1989;785-788.
36. Mehta K., Shahid U., Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J. 10:1996;1408-1417.
37. Benito J. M., Zabay J. M., Gil J. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 t lymphocytes in asymtopmatic HIV infection. J AIDS HR. 14:1997;128-135.
38. Puppo F., Brenci S., Bosco O. Downregulation of HLA class I antigen expression in CD4+ T lymphocytes from HIV type 1-infected individuals. AIDS Res Hum Retrovir. 13:1997;1509-1516.
39. Deterre P., Gelman L., Gary-Gouy H. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto- enzymatic activities including CD38 and PC-1. J Immunol. 157:1996;1381-1388.
40. Skurnick J. H., Bogden J. D., Baker H. Micronutrient profiles in HIV-1-infected heterosexual adults. J AIDS Hum Retrvirol. 12:1996;75-83.
41. Levy J. A., Mackewicz C. E., Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today. 17:1996;217-224.
42. Liu Z., Cumberland W. G., Hultin L. E., Prince H. E., Detals R., Giorgi J. V. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV progression to AIDS and death in the Multicenter AIDS cohort study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J AIDS HR. 16:1997;83-92.
43. Silvestri G., Munoz C., Butini L., Bagnarelli P., Montroni M. Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients. Viral Immunol. 10:1997;207-212.
44. DiPalma J. R., Thayer W. S. Use of niacin as a drug. Annu Rev Nutr. 11:1991;169-187.